{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-24-021113","form_type":"8-K","ticker":"INGN","cik":"0001294133","company_name":"Inogen Inc","filed_at":"2024-02-27T23:59:59+00:00","discovered_at":"2026-05-14T18:03:23.705376+00:00","generated_at":"2026-06-05T10:55:00.046935+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Inogen Q4 revenue $75.9M (-14% YoY); FY net loss $102.4M, adj EBITDA -$37.8M","bullets":["Q4 revenue $75.9M vs $88.1M YoY; full-year revenue $315.7M vs $377.2M in 2022.","Q4 GAAP net loss $26.6M vs $56.6M loss YoY; adjusted net loss $19.4M vs $13.0M loss.","Full-year GAAP net loss $102.4M vs $83.8M loss; adjusted EBITDA -$37.8M vs -$13.5M.","Cash, equivalents and marketable securities $128.5M, no debt; gross margin improved to 37.1% in Q4.","New CCO Grégoire Ramade and CFO Michael Bourque appointed; focus on Physio-Assist U.S. launch."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-24-021113","json":"https://secwatch.observer/filing/0000950170-24-021113.json","markdown":"https://secwatch.observer/filing/0000950170-24-021113.md","text":"https://secwatch.observer/filing/0000950170-24-021113.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1294133/000095017024021113/0000950170-24-021113-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1294133/000095017024021113/ingn-20240227.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-05T10:55:00.046935+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"d811288105fa99217d8daa76d475e283b33d7346","claim":"Inogen Inc reported the fourth quarter and the full year ended December 31, 2023 results: revenue $75.9 million; full-year 2023 revenue of $315.7 million, net income GAAP net loss for the fourth quarter of 2023 was $26.6 million compared to GAAP net loss of $56.6 million in the fourth.","evidence_excerpt":"Inogen Announces Fourth Quarter and Full-Year 2023 Financial Results Fourth quarter 2023 revenue of $75.9 million; full-year 2023 revenue of $315.7 million","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1294133/000095017024021113/0000950170-24-021113-index.htm","confidence":0.95,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the fourth quarter and the full year ended December 31, 2023"},{"label":"Revenue","value":"$75.9 million; full-year 2023 revenue of $315.7 million"},{"label":"Net income","value":"GAAP net loss for the fourth quarter of 2023 was $26.6 million compared to GAAP net loss of $56.6 million in the fourth"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}